Key Highlights

  • Harrow, Inc. (NASDAQ:HROW) indicated USD 31.63 pre-market on Tuesday, November 10, 2026, up 15.13% from a calculated prior close of USD 27.47, after results released November 9 at 4:02 p.m. ET.
  • Third quarter Revenue was USD 99.3 million, up 39% from USD 71.6 million, with branded revenue of USD 83.5 million, up 62%, and Gross Profit of USD 74.9 million at a 75% margin.
  • Net income was USD 9.8 million, or USD 0.25 per diluted share, including a USD 5.0 million litigation gain, while adjusted EBITDA was USD 21.2 million.
  • Full-year revenue guidance of USD 350 million to USD 365 million was reaffirmed, but adjusted EBITDA guidance was cut to above USD 40 million from USD 80 million to USD 100 million.

What Moved Harrow Pre-Market (15.13%)

Harrow released third quarter 2026 results on Monday, November 9, 2026, and the shares indicated USD 31.63 pre-market on Tuesday, up 15.13% from a calculated prior close of USD 27.47. Revenue of USD 99.3 million rose 41% sequentially and 39% from a year earlier. VEVYE revenue was USD 39.7 million, up 75%, IHEEZO was USD 25.3 million, up 15%, and TRIESENCE set a record at USD 10.7 million. Net Income of USD 9.8 million compares with a USD 17.3 million loss in the second quarter and USD 1.0 million income a year earlier. Adjusted EBITDA of USD 21.2 million compares with a loss of USD 1.2 million in the second quarter.

The Rationale Behind the Move

The catalyst appears to be the Earnings release and call, held at 8:00 a.m. ET on November 10. A sharp rebound in revenue and profit from a weak second quarter likely drove buying, even though full-year adjusted EBITDA guidance fell to above USD 40 million, with above USD 33 million expected in the fourth quarter. The company also completed the TYRVAYA Acquisition on October 1 and launched HarrowRx on November 1. The IHEEZO QUELL study missed its non-inferiority endpoint at 55.2% versus 59.7%, though adverse events were 27% versus 47%. General context: shares often jump when a quarter beats a depressed bar, and short covering can add to the move.

Valuation, Liquidity and Risk

A published snapshot showed 37.49 million shares, a 52-week range of USD 26.96 to USD 54.85 and a prior close of USD 28.95. At the calculated prior close of USD 27.47 the Equity value was about USD 1.03 billion, and at USD 31.63 it is about USD 1.19 billion, both calculated. The indicated price is still 42.3% below the 52-week high, calculated. Nine-month Operating Cash Flow was negative USD 27.4 million, notes payable were USD 292.7 million against cash of USD 75.3 million, and equity was USD 28.8 million, so Leverage is a risk. The snapshot showed a nine-analyst target of USD 63.00. Pre-market Volume is thin, spreads can be wide and the move can reverse at the open. Nothing here implies the move will continue, and the regular session may look very different.

Where Things Stand

Harrow, Inc. (NASDAQ:HROW) is rising 15.13% pre-market to USD 31.63 on Tuesday, November 10, 2026, most likely on record third quarter revenue of USD 99.3 million and a return to profit. The lower EBITDA outlook, USD 292.7 million of notes and negative nine-month cash flow temper the case, so the 9:30 a.m. ET open will show whether the gain holds.